Chiara L Sugarmann (Chiara Sugarmann)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Venous Thromboembolism

Randomized Controlled Trial

Direct Oral Anticoagulants

Top Venues

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Concetta Lipardi, C Gregory Elliott, Chiara L Sugarmann, Lloyd Haskell, Alex C Spyropoulos, Gary E Raskob, Jianfeng Xu, Wentao Lu, Jessica Marsigliano, Theodore Spiro, Zhong Yuan, Shujian Wu, Elliot S Barnathan
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 27 (2022)
Alex C Spyropoulos, Concetta Lipardi, Jianfeng Xu, Wentao Lu, Eunyoung Suh, Zhong Yuan, Bennett Levitan, Chiara L Sugarmann, Yoriko De Sanctis, Theodore E Spiro, Elliot S Barnathan, Gary E Raskob
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 25 (2020)